140 related articles for article (PubMed ID: 31115241)
1. Hypoxia inducible factor 1 inhibitors for cancer therapy.
Qing L; Qing W
Minerva Chir; 2019 Oct; 74(5):442-444. PubMed ID: 31115241
[No Abstract] [Full Text] [Related]
2. New drugs target hypoxia response in tumors.
Garber K
J Natl Cancer Inst; 2005 Aug; 97(15):1112-4. PubMed ID: 16077066
[No Abstract] [Full Text] [Related]
3. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives.
Otrock ZK; Hatoum HA; Awada AH; Ishak RS; Shamseddine AI
Crit Rev Oncol Hematol; 2009 May; 70(2):93-102. PubMed ID: 19186072
[TBL] [Abstract][Full Text] [Related]
4. Small molecule-mediated anti-cancer therapy via hypoxia-inducible factor-1 blockade.
Macpherson GR; Figg WD
Cancer Biol Ther; 2004 Jun; 3(6):503-4. PubMed ID: 15197355
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor-1: a novel target for cancer therapy.
Belozerov VE; Van Meir EG
Anticancer Drugs; 2005 Oct; 16(9):901-9. PubMed ID: 16162966
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials referral resource. Clinical trials with topotecan.
Cheson BD; Arbuck SG
Oncology (Williston Park); 1993 Feb; 7(2):49-51. PubMed ID: 8439468
[No Abstract] [Full Text] [Related]
7. Clinical trials referral resource. Trials of topotecan.
Cheson BD; Phillips PH; Arbuck SG
Oncology (Williston Park); 1995 Mar; 9(3):220, 224-6, 228. PubMed ID: 7669515
[No Abstract] [Full Text] [Related]
8. The development of camptothecin analogs in childhood cancers.
Bomgaars L; Berg SL; Blaney SM
Oncologist; 2001; 6(6):506-16. PubMed ID: 11743213
[TBL] [Abstract][Full Text] [Related]
9. An overview of topoisomerase I-targeting agents.
Arbuck SG; Takimoto CH
Semin Hematol; 1998 Jul; 35(3 Suppl 4):3-12. PubMed ID: 9779876
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase I inhibitors.
Takimoto CH; Kieffer LV; Arbuck SG
Cancer Chemother Biol Response Modif; 1997; 17():80-113. PubMed ID: 9551210
[No Abstract] [Full Text] [Related]
11. [A symphony for the camptothecins].
Lansiaux A; Bailly C
Bull Cancer; 2003 Mar; 90(3):239-45. PubMed ID: 12801826
[TBL] [Abstract][Full Text] [Related]
12. Differential activity of topotecan, irinotecan and SN-38 in fresh human tumour cells but not in cell lines.
Jonsson E; Dhar S; Jonsson B; Nygren P; Graf W; Larsson R
Eur J Cancer; 2000 Oct; 36(16):2120-7. PubMed ID: 11044651
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase I inhibitors: topotecan and irenotecan.
Creemers GJ; Lund B; Verweij J
Cancer Treat Rev; 1994 Jan; 20(1):73-96. PubMed ID: 8293429
[No Abstract] [Full Text] [Related]
14. Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part II.
Wilczynski J; Duechler M; Czyz M
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):301-7. PubMed ID: 21625847
[TBL] [Abstract][Full Text] [Related]
15. [Topoisomerase I inhibitors. Review of phase II trials with irinotecan (CPT-11) and topotecan].
Bonneterre J
Bull Cancer; 1995 Aug; 82(8):623-8. PubMed ID: 7492818
[TBL] [Abstract][Full Text] [Related]
16. HIF repressors under chronic hypoxia.
Luo W; Wang Y
Aging (Albany NY); 2016 Mar; 8(3):418-9. PubMed ID: 26954058
[No Abstract] [Full Text] [Related]
17. Clinical use of topoisomerase I inhibitors in anticancer treatment.
Rodriguez-Galindo C; Radomski K; Stewart CF; Furman W; Santana VM; Houghton PJ
Med Pediatr Oncol; 2000 Oct; 35(4):385-402. PubMed ID: 11025469
[TBL] [Abstract][Full Text] [Related]
18. Clinical development of topoisomerase-interactive drugs.
Muggia FM; Burris HA
Adv Pharmacol; 1994; 29B():1-31. PubMed ID: 8996599
[No Abstract] [Full Text] [Related]
19. Topotecan: an important new drug in the management of ovarian cancer.
Markman M
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-1. PubMed ID: 9122736
[No Abstract] [Full Text] [Related]
20. Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor.
Pastorino F; Loi M; Sapra P; Becherini P; Cilli M; Emionite L; Ribatti D; Greenberger LM; Horak ID; Ponzoni M
Clin Cancer Res; 2010 Oct; 16(19):4809-21. PubMed ID: 20702613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
